Coherus Oncology
CHRS
CHRS
183 hedge funds and large institutions have $975M invested in Coherus Oncology in 2022 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 59 increasing their positions, 72 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
46% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 39
98% less call options, than puts
Call options by funds: $11K | Put options by funds: $616K
Holders
183
Holding in Top 10
–
Calls
$11K
Puts
$616K
Top Buyers
| 1 | +$17.3M | |
| 2 | +$4.88M | |
| 3 | +$3.93M | |
| 4 |
D.E. Shaw & Co
New York
|
+$3.49M |
| 5 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
+$2.66M |
Top Sellers
| 1 | -$19.5M | |
| 2 | -$11.3M | |
| 3 | -$9.19M | |
| 4 |
Swedbank
Stockholm,
Sweden
|
-$4M |
| 5 |
FAM
Fred Alger Management
New York
|
-$3.34M |